Supplementary Figure 2 from Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages

Bitransgenic mice were fed dox for 7 weeks and treated with a depleting antibody against CSF-1R every other day. Expression of MHC-II and CD40 were evaluated by flow cytometry (A) and tumor burden was evaluated by H-E staining on lung tissue sections (B).